ASX 200 healthcare shares have had a rollercoaster ride in 2020. While the S&P/ASX 200 Index (ASX: XJO) is down 18.36% this year, the nature of the coronavirus pandemic has meant investors are snapping up healthcare companies like there's no tomorrow.
Here are a couple of my top healthcare shares to buy for a good price today!
2 ASX 200 healthcare shares to buy today
I like the look of CSL Limited (ASX: CSL) shares right now. The biotech giant's share price closed at $290.93 on Friday and boasts a $132 billion market capitalisation.
On the surface, that may seem expensive. However, I think we've seen some strong support for CSL shares at the $300 per share mark. Given the group's size and demand for its products, the ASX 200 healthcare share could be in the buy zone.
Despite climbing higher in 2020, the CSL share price is down 11% since early April. That could mean now is a good time to buy in and hold a blue-chip share for the long-term.
Other than CSL, I think Polynovo Ltd (ASX: PNV) shares could be in the buy zone. Polynovo develops and manufactures polymers to assist with the treatment of burns and its share price has been flying in recent years.
In fact, the ASX 200 healthcare share is up more than 100% since 23 March and more than 3,300% in the last 5 years.
Those are some strong growth numbers and there could be more on the way. The Aussie biotech group is going from strength to strength and posted record US quarterly sales in the March quarter.
The group's NovoSorb Biodegradable Temporising Matrix (BTM) product has had success in a number of countries and received widespread praise from the medical community.
There's still further market share for Polynovo to capture and a strong research and development pipeline could drive further growth for the ASX 200 healthcare share.
Foolish takeaway
ASX 200 healthcare shares could be good buy options in the COVID-19 environment. There are strong dividend and growth shares for savvy investors but you just have to know where to look…
